Efficacy and Safety of Anti-cancer Biosimilars Compared to Reference Biologics in Oncology: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Jichun YangShuqing YuZhirong YangYusong YanYao ChenHongmei ZengFei MaYanxia ShiYehui ShiZilu ZhangFeng Sun

Published in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2019)

The existing evidence suggests highly comparable efficacy and safety profiles between mAb biosimilars and their reference biologics in oncological drugs.

Keyphrases

systematic review
palliative care
rectal cancer
radical prostatectomy
prostate cancer
robot assisted
monoclonal antibody
drug induced